Likewise, Fontana et al. focused their research on the analysis of the influence of EGFR activity on HO-1 function in glioma cell lines: U87MG (low EGFR expression), LN229EGFR (EGFR overexpression), and BS153 (EGFRvIII mutation). Here, HMOX1 is linked to central nervous system cancer.